Johnson & Johnson (NYSE:JNJ)

bull and bear

The 11 Most Attractive Dow Stocks for 2017: Is DJIA 22,000 in the Cards?

As 2016 winds down and 2017 becomes the prevailing concern, investors have to wonder what to expect. Donald Trump unexpectedly beat Hillary Clinton in the presidential election, and now both sides ...
Read Full Story »
buy sell stocks

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

Monday brought a much needed sell-off after two and half weeks of almost constant rallying, but the sell-off was minimal. Tuesday's opening indication on the S&P 500 and Dow is ...
Read Full Story »
market crash

Nike, Visa Lead DJIA Down on Monday

November 28, 2016: Markets opened lower Monday after a long weekend of eating and shopping. There was no economic news of note, so this may just be a pause in ...
Read Full Story »
installing solar panels

Target, Walmart Lead Top 10 Adopters of Solar Energy

Solar energy adoption among large U.S. corporations has grown from a total installed base of 300 megawatts (MW) in 2012 to more than 1,000 MW this year. The total represents ...
Read Full Story »
passenger cabin

Major Changes in Warren Buffett & Berkshire Hathaway Stocks: American Airlines, Delta, Kinder Morgan, Wal-Mart, BNY Mellon and More

Berkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2016. Outside of Warren Buffett being one of the richest men alive and being considered the ...
Read Full Story »
KMI Tanker

Massive Energy Trade Highlights Insider Blue Chip Buying: Kinder Morgan, AT&T, Kimberly-Clark, IBM, Johnson & Johnson and More

With the busiest earnings week behind us, it appears some of the restriction windows at major U.S. corporations are starting to open up a little. While the volume was still ...
Read Full Story »
Unhealthy Person

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes PLC (NASDAQ: ALKS) just announced positive Phase 3 results for its novel antidepressant ALKS 5461, and it’s serving as a rising tide — a storm surge even — for many biotech ...
Read Full Story »
Dow

5 Dow Stocks Outperforming Analyst Expectations for 2016

The stock market has enjoyed a wild ride in 2016. The drop at the start of the year and the post-Brexit panic were swept to the side, and investors just ...
Read Full Story »
Johnson & Johnson logo

Johnson & Johnson Remains Flat Despite Earnings Beat

Johnson & Johnson (NYSE: JNJ) released its third-quarter earnings report before the markets opened on Tuesday. The company said that it had $1.68 in earnings per share (EPS) and $17.8 ...
Read Full Story »
Johnson & Johnson logo

What to Look for in Johnson & Johnson Earnings

Johnson & Johnson (NYSE: JNJ) is set to release its most recent earnings report before the markets open on Tuesday. With a diverse product base and a very popular and ...
Read Full Story »
Dow

Top DJIA Earnings Reports in the Week Ahead

Third-quarter earnings reporting season is underway, and 24/7 Wall St. has put together a preview of some of the major Dow Jones Industrial Average (DJIA) companies scheduled to report their ...
Read Full Story »
Jon's friends

4 DJIA Stocks That Have Raised Dividends for Over 50 Years Straight

It is no secret at all that investors love dividends. Companies raising dividends continuously are even more sought after than those just paying the same old dividend year in and year ...
Read Full Story »
Jon's friends

7 Giant Companies Raising Their Dividends for 25 Years or More

It is no secret that investors love receiving dividends. With up to half (or more) of all total returns through time coming from dividends, companies that are raising their dividends ...
Read Full Story »
FDA_logo

New Crohn’s Disease Drug Approved by FDA

Johnson & Johnson (NYSE: JNJ) is often not very vocal about receiving drug approvals, at least not using its own name. Janssen Biotech, a unit of Johnson & Johnson's Janssen ...
Read Full Story »
clinical trials

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward. One key analyst issued a few of its top picks ...
Read Full Story »